JUN and breast cancer: Additionally, activation of ZEB1/2 has been connected to NF-ĸB signaling in breast cancer cells [47], suggesting an involvement of the MAPK, NF-ĸB and AP-1 pathways in tumorigenesis through activation of EMT.